Antibody-based approach to destroy deadly ovarian cancer
Researchers are developing an antibody-based approach to destroy deadly ovarian cancer -- an approach that could also be modified to kill breast, prostate and other solid tumours...
List view / Grid view
Researchers are developing an antibody-based approach to destroy deadly ovarian cancer -- an approach that could also be modified to kill breast, prostate and other solid tumours...
Tumours with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting precision medicine approach...
Cancer researchers have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers...
A test of contrast-enhanced subharmonic imaging has shown promise in detecting prostate cancers that were not identified by MRI...
Scientists have discovered that cells lacking the tumour-suppressor protein PTEN – a feature of many cancers – are particularly vulnerable to drugs that impair their energy-producing mitochondria.
A new approach to analysing prostate gland tissue may help address a major challenge in treating prostate cancer...
Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients.
A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy...
Analysing individuals' genotypes and immunotypes could yield customised treatments for prostate cancer...
Researchers identify a pathway that causes tumour acceleration in metastatic prostate cancer cells...
British scientists have investigated the impact of anti-hormone therapy on patients with prostate cancer...
Scientists have described a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA...
Patients who have aggressive prostate cancer could be identified by a highly accurate and simple blood test, according to a new study.
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
Screening for prostate cancer is controversial. It can save lives, but it can also lead to unnecessary diagnoses, followed by surgical or radiation procedures, which themselves may lead to severe side-effects.